What's Happening?
The Department of Justice's Civil Division, in partnership with the Department of Health and Human Services (HHS), has initiated a Healthcare False Claims Act Self-Disclosure Pilot Program (FCA SDPP). This program aims to provide healthcare companies
with a structured pathway to resolve past misconduct by voluntarily disclosing potential violations of the federal False Claims Act (FCA). The FCA SDPP is designed to streamline the resolution of corporate misconduct, recover damages and penalties for taxpayers, and allow the government to focus its resources on entities unwilling to cooperate. Companies participating in the program will receive a coordinated civil release from liability under the federal False Claims Act and specific HHS administrative authorities. Assistant Attorney General Brett A. Shumate emphasized that voluntary self-disclosure indicates a company's commitment to compliance and accountability, while Deputy Assistant Attorney General Brenna Jenny highlighted the predictable and clear incentives for self-disclosure, enabling responsible companies to strengthen their partnership with federal healthcare programs.
Why It's Important?
This pilot program is significant for several reasons. It offers a clear framework for healthcare companies to address and rectify past non-compliance, potentially avoiding more severe penalties that could arise from government investigations. By encouraging self-disclosure, the program aims to recover funds for taxpayers more efficiently, as companies are required to make financial repayments with a multiplier ranging from 1.25 to 1.6. This approach also allows the Justice Department to reallocate resources, focusing on deliberate exploiters of the healthcare system rather than companies willing to take responsibility. For the healthcare industry, the program provides a degree of predictability in resolving misconduct, fostering a more transparent and accountable environment. Companies that proactively identify and address issues can mitigate reputational damage and maintain their standing within federal healthcare programs, while those that fail to comply face continued scrutiny and potential legal action.
What's Next?
Healthcare companies interested in participating in the FCA SDPP can submit self-disclosures electronically to FCA-SDPP@usdoj.gov. The program will accept submissions until April 22, 2027. Participants must provide comprehensive details regarding their conduct that potentially violates the federal FCA and submit documentation fully reflecting the nature and scope of these violations. They must also outline the remedial actions taken and agree to a financial repayment. The specific multiplier applied to the repayment will depend on factors such as the timeliness of disclosure, the duration and scope of misconduct, the involvement of senior leadership, the financial benefit to the company, and whether the company has successor liability but promptly remediated. Late or incomplete submissions will not be reviewed. The success of this pilot program could influence future anti-fraud initiatives and compliance frameworks within the healthcare sector.
